Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

How to Implement FIFO and FEFO in Warehouse Management Systems

Posted on November 25, 2025November 25, 2025 By digi


How to Implement FIFO and FEFO in Warehouse Management Systems

Step-by-Step Guide to Implementing FIFO and FEFO in Pharmaceutical Warehouses

Effective inventory management is essential for ensuring product quality and regulatory compliance within pharmaceutical warehouses. The correct application of fifo and fefo in pharmaceutical warehouses prevents the distribution of expired or degraded products, reduces waste, and supports traceability and quality assurance. This step-by-step tutorial explains how to implement First-In, First-Out (FIFO) and First-Expired, First-Out (FEFO) methodologies within a Warehouse Management System (WMS), tailored specifically for pharmaceutical manufacturing, quality assurance, supply chain professionals, and regulatory personnel in the US, UK, and EU environments.

Understanding FIFO and FEFO Principles in Pharmaceutical Warehousing

Before implementing these inventory control methods, it is crucial to grasp their definitions and regulatory importance:

  • FIFO (First-In, First-Out): This system ensures that materials or products received earliest are issued or dispatched first. It is typically based on the receipt date or manufacturing date. FIFO helps avoid product obsolescence and prevents stock from being held beyond its expiry.
  • FEFO (First-Expired, First-Out): Under this approach, the products with the earliest expiry date are issued before others, regardless of receipt date. FEFO is especially critical in handling multi-batch pharmaceutical inventories where stability and potency are time-sensitive.

Pharmaceutical regulations such as FDA 21 CFR Part 211, EU GMP Annex 11, and PIC/S guidance require strict inventory rotation controls to prevent expired or compromised products from reaching patients. The adherence to FIFO and FEFO supports compliance with these regulations and minimizes risk in product supply chains.

Implementing these principles effectively demands integration into an automated warehouse management system (WMS) that can apply programmatic system rules, ensuring controlled stock movement, real-time tracking, and audit trail generation.

Step 1: Assess Warehouse Inventory and Operational Requirements

The first critical step before system configuration is to conduct a comprehensive assessment of the warehouse setup, inventory characteristics, and operational procedures. This step includes:

  • Inventory Profiling: Identify all pharmaceutical products stored, including their batch characteristics, expiry profiles, and special handling requirements (e.g., cold chain, hazardous substances).
  • Storage Environment Analysis: Evaluate how products are physically stored — racks, bins, or bulk areas — and the presence of segregated zones for quarantined, rejected, or returned goods.
  • Review Regulatory and Quality Requirements: Consider standards such as FDA 21 CFR Part 211.142 on materials control and EU GMP Annex 15 on qualification and validation of computerized systems to define key controls related to inventory rotation.
  • Define FIFO vs. FEFO Application: Determine which products require FIFO (e.g., stable raw materials) and which need FEFO (e.g., products with varying expiry dates or perishable goods).
  • Map User Roles and Access: Specify how operators, warehouse managers, QA personnel, and auditors will interact with the system to ensure process integrity and traceability.
Also Read:  FIFO and FEFO in Pharmaceutical Warehouses: Why Both Matter

Documenting these requirements establishes the foundation for developing robust system rules within the WMS that enforce correct inventory rotation logic and support regulatory audits.

Step 2: Design Warehouse Layout and Labeling to Support FIFO and FEFO

The physical and labeling arrangements in the warehouse must complement the FIFO and FEFO logic to facilitate accurate picking and dispatch. Key design considerations include:

  • Storage Location Coding: Implement clear, logical location codes that align with system definitions in the WMS, allowing easy reference for pickers and validators.
  • Physical Segregation: Designate specific storage areas for products at different expiry stages or quarantine statuses to prevent mix-ups.
  • Labeling Strategies: Use standardized labels incorporating batch number, manufacturing date, expiry date, and unique identifiers such as barcodes or QR codes. High-quality labels allow error-free scanning, critical for enforcing FIFO and FEFO logic.
  • Expiry Date Visibility: Position products to enable visual inspection of expiry dates to supplement system controls.
  • Cross-Docking and Staging Areas: Establish temporary zones where incoming stock can be checked and integrated into FIFO/FEFO flow before final shelving.

By focusing on appropriate warehouse design and label scanning capabilities, you ensure the accuracy of digital records and physical stock movements. This synergy reduces the risk of expired product usage and facilitates transition between physical picking and the automated systems.

Step 3: Configure Your Warehouse Management System to Enforce FIFO and FEFO Rules

Having assessed the operational environment and established warehouse design, the next step is to configure the WMS software with robust FIFO and FEFO logic. This involves:

  • Set Up Product Master Data: Input required product attributes including batch numbers, manufacturing dates, and expiry dates. Ensure date formats and data validation rules prevent entry errors.
  • Define Inventory Rotation Rules: Program system rules that automatically prioritize inventory picks based on FIFO or FEFO criteria, depending on the product category. The WMS must be capable of dynamically sorting available stock by expiry or receipt date.
  • Integrate Label Scanning: Incorporate barcode or RFID scanning at key process points (receiving, put-away, picking, dispatch) to confirm the correct stock is moved, preventing human errors.
  • Automate Alerts and Holds: Enable system warnings or holds for stock approaching expiry or when FIFO/FEFO violations occur. This supports proactivity in inventory management and compliance with regulatory frameworks such as EU GMP Volume 4.
  • Enable Traceability and Audit Trails: Ensure every inventory movement is time-stamped, user-attributed, and stored securely to facilitate inspection readiness per PIC/S and FDA 21 CFR Part 11 requirements.
  • Testing and Validation: Conduct extensive functional testing to confirm system rules behave as intended under varied scenarios (multi-batch picking, expiry updates, product returns). Validation documents must comply with regulatory expectations on computerized systems.
Also Read:  Assay and Content Uniformity Testing: QC Laboratory Best Practices

Configuring the WMS with precise FIFO and FEFO enforcement ensures systematic control of pharmaceutical stock flows, reducing risk of expired or incorrectly rotated products leaving the warehouse.

Step 4: Train Personnel and Implement Standard Operating Procedures (SOPs)

Even the most sophisticated systems can fail without competent human interaction and process adherence. This step involves:

  • Develop SOPs Focused on Inventory Rotation: Clearly document responsibilities, procedures for receiving, storing, picking, and shipping under FIFO and FEFO rules. SOPs should include protocols for handling exceptions like returns or recalls.
  • Conduct Role-Based Training: Provide comprehensive training for warehouse operators, QA staff, and supervisors on the purpose and application of FIFO/FEFO rules, use of WMS and scanning devices, and adherence to regulatory mandates.
  • Promote Continuous Quality Checks: Train personnel on routine stock rotation verification and cycle counting methods to detect and correct deviations promptly.
  • Simulate System Use: Use practical exercises and scenario testing to build proficiency in handling complex situations such as multi-batch picking or managing quarantine inventory.
  • Assess Competency Periodically: Implement refresher training and competency assessments to maintain high standards and address turnover risks.
Also Read:  How to Handle and Record Discrepancies During Raw Material Receipt

Robust training combined with clearly defined procedures underpins successful and compliant fifo and fefo in pharmaceutical warehouses, ensuring that technological controls are effectively complementing manual processes.

Step 5: Monitor Compliance and Continuously Improve FIFO and FEFO Processes

Maintaining compliance requires ongoing monitoring and process improvement focused on these key activities:

  • Regular Audits and Inspections: Conduct internal audits and mock regulatory inspections reviewing inventory rotation practices, label scanning accuracy, WMS logs, and deviation handling. This supports compliance with MHRA and EMA expectations.
  • Performance Metrics: Track key performance indicators such as stock expiry rates, order picking accuracy, and system overrides to detect process weaknesses.
  • Exception Management: Analyze root causes of FIFO/FEFO breaches such as picking errors, labeling mistakes, or system malfunctions and implement corrective actions.
  • System Updates and Maintenance: Maintain WMS software with timely updates, security patches, and functional enhancements to support evolving regulatory and operational requirements.
  • Feedback Loops: Encourage frontline staff to report challenges or suggest improvements in applying FIFO and FEFO, facilitating continuous quality improvement in supply chain management.

These proactive measures enable pharmaceutical warehouses to sustain effective system rules enforcement and maintain the high quality and safety standards demanded by US, UK, and EU regulatory authorities. Comprehensive monitoring also supports readiness for regulatory evaluations including FDA inspections and EMA audits.

Conclusion

Implementing fifo and fefo in pharmaceutical warehouses is a critical component of GMP-compliant supply chain management. By following this step-by-step guide—from operational assessment, warehouse design, WMS configuration, personnel training, through to ongoing monitoring—pharmaceutical companies can ensure reliable inventory rotation, protect product integrity, and meet stringent regulatory requirements.

Automation through a validated WMS combined with effective label scanning and defined system rules significantly reduces human error and enables timely interventions. This integrated approach supports robust pharmaceutical quality systems consistent with FDA 21 CFR 211, EU GMP Volume 4, and PIC/S guidelines.

For detailed regulatory guidance on computerized system controls and inventory management, consult the official FDA guidance on Part 11, the EU GMP Volume 4, and the PIC/S Good Practices Guide.

FIFO & FEFO Tags:fefo, fifo, implementation, pharmagmp, wms

Post navigation

Previous Post: Common Mistakes in Applying FIFO and FEFO in Practice
Next Post: FIFO and FEFO in Pharmaceutical Warehouses: Why Both Matter

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme